These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 32629192)
1. Enlightening the advancements in electrochemical bioanalysis for the diagnosis of Alzheimer's disease and other neurodegenerative disorders. Serafín V; Gamella M; Pedrero M; Montero-Calle A; Razzino CA; Yáñez-Sedeño P; Barderas R; Campuzano S; Pingarrón JM J Pharm Biomed Anal; 2020 Sep; 189():113437. PubMed ID: 32629192 [TBL] [Abstract][Full Text] [Related]
2. Applications of biosensors in Alzheimer's disease diagnosis. Brazaca LC; Sampaio I; Zucolotto V; Janegitz BC Talanta; 2020 Apr; 210():120644. PubMed ID: 31987214 [TBL] [Abstract][Full Text] [Related]
3. Electrochemical Immunosensors Developed for Amyloid-Beta and Tau Proteins, Leading Biomarkers of Alzheimer's Disease. Sharma A; Angnes L; Sattarahmady N; Negahdary M; Heli H Biosensors (Basel); 2023 Jul; 13(7):. PubMed ID: 37504140 [TBL] [Abstract][Full Text] [Related]
4. Recent Electrokinetic and Microfluidic Strategies for Detection of Amyloid Beta Peptide Biomarkers: Towards Molecular Diagnosis of Alzheimer's Disease. Van Thanh Nguyen N; Taverna M; Smadja C; Mai TD Chem Rec; 2021 Jan; 21(1):149-161. PubMed ID: 33112020 [TBL] [Abstract][Full Text] [Related]
5. Surface plasmon resonance biosensors for detection of Alzheimer's biomarkers; an effective step in early and accurate diagnosis. Rezabakhsh A; Rahbarghazi R; Fathi F Biosens Bioelectron; 2020 Nov; 167():112511. PubMed ID: 32858422 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of the use of biomarkers in cerebrospinal fluid for Alzheimer's disease. Valcárcel-Nazco C; Perestelo-Pérez L; Molinuevo JL; Mar J; Castilla I; Serrano-Aguilar P J Alzheimers Dis; 2014; 42(3):777-88. PubMed ID: 24916543 [TBL] [Abstract][Full Text] [Related]
7. The use of proteomics in biomarker discovery in neurodegenerative diseases. Davidsson P; Sjögren M Dis Markers; 2005; 21(2):81-92. PubMed ID: 15920295 [TBL] [Abstract][Full Text] [Related]
8. A Concise Overview of Biosensing Technologies for the Detection of Alzheimer's Disease Biomarkers. Talebi M; Esmaeeli H; Talebi M; Farkhondeh T; Samarghandian S Curr Pharm Biotechnol; 2022; 23(5):634-644. PubMed ID: 34250871 [TBL] [Abstract][Full Text] [Related]
9. Biomarkers in the Diagnosis and Prognosis of Alzheimer's Disease. Schaffer C; Sarad N; DeCrumpe A; Goswami D; Herrmann S; Morales J; Patel P; Osborne J J Lab Autom; 2015 Oct; 20(5):589-600. PubMed ID: 25424384 [TBL] [Abstract][Full Text] [Related]
10. Biosensors for Alzheimer's disease biomarker detection: A review. Shui B; Tao D; Florea A; Cheng J; Zhao Q; Gu Y; Li W; Jaffrezic-Renault N; Mei Y; Guo Z Biochimie; 2018 Apr; 147():13-24. PubMed ID: 29307704 [TBL] [Abstract][Full Text] [Related]
11. Multiplexed femtomolar detection of Alzheimer's disease biomarkers in biofluids using a reduced graphene oxide field-effect transistor. Park D; Kim JH; Kim HJ; Lee D; Lee DS; Yoon DS; Hwang KS Biosens Bioelectron; 2020 Nov; 167():112505. PubMed ID: 32841782 [TBL] [Abstract][Full Text] [Related]
12. The discriminative capacity of CSF β-amyloid 42 and Tau in neurodegenerative diseases in the Chinese population. Ye LQ; Li XY; Zhang YB; Cheng HR; Ma Y; Chen DF; Tao QQ; Li HL; Wu ZY J Neurol Sci; 2020 May; 412():116756. PubMed ID: 32142967 [TBL] [Abstract][Full Text] [Related]
13. Electrochemical aptamer-based nanobiosensors for diagnosing Alzheimer's disease: A review. Negahdary M; Angnes L Mater Sci Eng C Mater Biol Appl; 2022 Apr; 135():112689. PubMed ID: 35581077 [TBL] [Abstract][Full Text] [Related]
14. Recent Advancements in Electrochemical Biosensors for Alzheimer's Disease Biomarkers Detection. Mikuła E Curr Med Chem; 2021; 28(20):4049-4073. PubMed ID: 33176635 [TBL] [Abstract][Full Text] [Related]
16. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia. Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675 [TBL] [Abstract][Full Text] [Related]
17. Analysis of Cerebrospinal Fluid and [11C]PIB PET Biomarkers for Alzheimer's Disease with Updated Protocols. Wang MJ; Yi S; Han JY; Park SY; Jang JW; Chun IK; Giau VV; Bagyinszky E; Lim KT; Kang SM; An SS; Park YH; Youn YC; Kim S J Alzheimers Dis; 2016 May; 52(4):1403-13. PubMed ID: 27163824 [TBL] [Abstract][Full Text] [Related]
18. Electrochemical biosensors for biometal-protein interactions in neurodegenerative diseases. Li S; Kerman K Biosens Bioelectron; 2021 May; 179():113035. PubMed ID: 33578115 [TBL] [Abstract][Full Text] [Related]
19. Comparison of Two Analytical Platforms in Cerebrospinal Fluid Biomarkers for the Classification of Alzheimer's Disease Spectrum with Amyloid PET Imaging. Lim HJ; Park JE; Kim BC; Choi SM; Song MK; Cho SH; Seo HJ; Kim J; Song HC; Choi KY; Lee JJ; Kim HW; Ha JM; Song WK; Park SG; Lee JS; Lee KH J Alzheimers Dis; 2020; 75(3):949-958. PubMed ID: 32390627 [TBL] [Abstract][Full Text] [Related]
20. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease. Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]